BioNTech (BNTX) Stock Price, Quote, News & History | Benzinga

SPY778.18+0.43%QQQ760.50 BTC/USD85,963.00+0.25%DIA514.85+0.54%GLD382.55+0.79%TLT77.27+0.21%

BioNTech SE (BNTX) Stock Price, Quote, News & History

BNTXNASDAQ

Trade with Public

Trade with Public

$97.64

0.740.76%

Last update: Oct 6, 8:59 AM

$98.98

2.082.15%

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

-

Close

$97.64

Volume / Avg.

13.01K / 1.15M

Day Range

- - -

52 Wk Range

79.52 - 124.00

Market Cap

$25.03B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

51

Short Interest

3.39%

Days to Cover

2.59

Recent Biontech SE News

Invivyd Outlines Accelerated Approval Submission Path with FDA for COVID-19 Antibody

Invivyd reported Phase 3 LIBERTY trial data for VYD2311, showing strong safety and enhanced COVID-19 antibody levels.

Vandana Singh

Why Is BioNTech Stock Gaining Monday?

BioNTech (BNTX) Phase 3 data reveals gotistobart almost doubles survival in advanced lung cancer over standard docetaxel.

Vandana Singh

This Best Buy Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Tuesday

Analysts downgraded BioNTech, Gulfport Energy, Amgen and Best Buy; price targets fell for BioNTech and Gulfport.

Avi Kapoor

Robinhood To Rally Around 23%? Here Are 10 Top Analyst Forecasts For Tuesday

Analysts raised targets for NOW, HOOD, MSTR, ABNB and CLYM, while cutting APP and IONS; ratings largely remain positive.

Avi Kapoor

Take Two Interactive, Nvidia, Cheniere Energy And A Health Care Stock: CNBC’s ‘Final Trades’

Take-Two Interactive Software, on Aug. 7, reported adjusted earnings were 35 cents per share, topping the analyst consensus of 33 cents.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

679.70M

Investing Cash Flow (TTM)

-1.10B

Financing Cash Flow (TTM)

-107.90M

Free Cash Flow (TTM)

444.70M

Capital Expenditure (TTM)

-235.00M

Net Change in Cash (TTM)

-528.60M

Analyst Trends and Forecast

2

Apr

3

1

May

1

Jul

3

Aug

1

Sep

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.6

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$8.25B

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

8.11

PB Ratio (TTM)

1.23

Earnings Yield % (TTM)

-7.74%

Earnings Yield % (FWD)

-8.28%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

48.35

Book Value / Share

$79.57

Company Debt

Total Debt

$316.10M

LT Debt

$258.90M

LT Debt Issuance (TTM)

$82.90M

LT Debt Repayment (TTM)

-$59.60M

Total Cash

$9.74B

Debt to Equity

0.02

Issuance of Debt (TTM)

$23.30M

Repayment of Debt (TTM)

-$59.60M